Canadian Patent Granted for RECCE Anti-Infectives

® ® ® ® ® transdermal or transmucosal delivery) This is the first of Recce’s wholly owned patents Granted in Canada, with further Patent Cooperation Treaty Country (PCT) submissions in respective stages of review. In July 2023, the Company received AUD $98,428 R&D Rebate from the Canadian Government, under the Scientific Research & Experimental Development (SR&ED) Tax Incentive program. The progra